NCT04902131View on ClinicalTrials.gov

A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women

PHASE1CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

August 15, 2022

Study Completion Date

August 15, 2022

Conditions
Infertility, Female
Interventions
DRUG

A MENOPUR solution for injection in pre-filled pen, 600 IU/0.96 mL

Single dose cross-over bioequivalence trial

DRUG

A MENOPUR powder including solvent for solution for injection, 75 IU

Single dose cross-over bioequivalence trial

Trial Locations (2)

210029

Ferring investigational site, Nanjing

210032

Ferring investigational site, Nanjing

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY